NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $2.16 -0.09 (-3.78%) As of 03:26 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Health Catalyst Stock (NASDAQ:HCAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Health Catalyst alerts:Sign Up Key Stats Today's Range$2.14▼$2.2550-Day Range$1.17▼$2.3352-Week Range$0.96▼$4.11Volume500,631 shsAverage Volume1.14 million shsMarket Capitalization$159.90 millionP/E RatioN/ADividend YieldN/APrice Target$2.84Consensus RatingHold Company Overview Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information. The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis. In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions. Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.AI Generated. May Contain Errors. Read More Health Catalyst Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreHCAT MarketRank™: Health Catalyst scored higher than 75% of companies evaluated by MarketBeat, and ranked 143rd out of 840 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingHealth Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.Upside PotentialHealth Catalyst has a consensus price target of $2.84, representing about 31.2% upside from its current price of $2.17.Amount of Analyst CoverageHealth Catalyst has only been the subject of 4 research reports in the past 90 days.Read more about Health Catalyst's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.25) to ($0.24) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.72% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 2.12, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently decreased by 27.60%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.46 News SentimentHealth Catalyst has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search InterestOnly 8 people have searched for HCAT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have not sold or bought any company stock.Percentage Held by Insiders19.40% of the stock of Health Catalyst is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCAT Stock News HeadlinesHealth Catalyst, Commerce, and Paycom Shares Plummet, What You Need To KnowJuly 18 at 1:19 PM | finance.yahoo.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Hold" by BrokeragesJuly 18 at 2:14 AM | americanbankingnews.comBuy this stock tomorrowMarc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.July 20 at 1:00 AM | Chaikin Analytics (Ad)3 Reasons to Sell HCAT and 1 Stock to Buy InsteadJuly 15, 2026 | finance.yahoo.comFinancial Analysis: Standard BioTools (NASDAQ:LAB) and Health Catalyst (NASDAQ:HCAT)July 11, 2026 | americanbankingnews.comHCAT Share News TodayJuly 8, 2026 | uk.investing.comMonday.com, Intuit, and Health Catalyst stocks trade down, what you need to knowJuly 8, 2026 | msn.comHealth Catalyst, PubMatic, and PTC stocks trade up, what you need to knowJuly 1, 2026 | msn.comSee More Headlines HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $2.39 at the beginning of 2026. Since then, HCAT stock has decreased by 9.4% and is now trading at $2.1650. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) posted its earnings results on Monday, May, 11th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of $0.01 by $0.01. The business had revenue of $70.76 million for the quarter, compared to analyst estimates of $69.24 million. Health Catalyst had a negative trailing twelve-month return on equity of 3.52% and a negative net margin of 87.69%. Read the conference call transcript. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $172 million in an initial public offering on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Top institutional shareholders of Health Catalyst include Williams & Novak LLC (0.07%). Insiders that own company stock include Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/11/2026Today7/20/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 HCAT's financial health is in the Green zone, according to TradeSmith. HCAT has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryComputer Software Current SymbolNASDAQ:HCAT CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year Founded2008Price Target and Rating Average Price Target for Health Catalyst$2.84 High Price Target$5.00 Low Price Target$1.75 Potential Upside/Downside+31.9%Consensus RatingHold Rating Score (0-4)2.23 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($3.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$177.97 million Net Margins-87.69% Pretax Margin-87.39% Return on Equity-3.52% Return on Assets-1.77% Debt Debt-to-Equity Ratio1.10 Current Ratio1.69 Quick Ratio1.69 Sales & Book Value Annual Sales$311.14 million Price / Sales0.51 Cash Flow$2.03 per share Price / Cash Flow1.06 Book Value$3.47 per share Price / Book0.62Miscellaneous Outstanding Shares73,890,000Free Float59,559,000Market Cap$159.16 million OptionableOptionable Beta1.56 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:HCAT) was last updated on 7/20/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredSMX: From Under-the-Radar to Must-Watch!SMX (Security Matters) PLC is building Digital Material Passport technology that embeds molecular-level marker...Smallcaps Daily | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredAmerican’s Biggest Threat Is HereThis feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...Goldco Direct, LLC | SponsoredThey proved it worked in '76. Then buried it.In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCAT Stock Alerts